4, 6-0-benzylidene-D-glucopyranose (BG) in the treatment of solid malignant tumours, an extended phase I study.

4, 6-0-Benzylidene-D-glucopyranose (BG), a derivative of benzaldehyde (BA), whose anti-tumour action has often been reported, showed responses in 10 out of 24 patients (41.7%). These patients consisted of 11 cases of primary lung cancer, 4 of metastatic lung cancer, 5 of gastric cancer, and one each...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatsumura, T., Tsujimoto, M., Koyama, S., Furuno, T., Komori, Y., Sato, H., Yamamoto, K., Kitagawa, M., Kagamimori, S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971458/
https://www.ncbi.nlm.nih.gov/pubmed/2206951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971458/
https://www.ncbi.nlm.nih.gov/pubmed/2206951

Ejemplares similares